“…AKT, kinase-protein kinase B; ERK1/2, extracellular regulated protein kinases 1/2; MAPK, mitogen-activated protein kinase; JNK, c-Jun NH2-terminal kinase; PDAC, pancreatic ductal adenocarcinoma; YAP, Yes-associated protein; TAZ, tafazzin; PI3K, promoting phosphatidylinositol 3; CHM-1, 2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone; NPC, nasopharyngeal carcinoma; FMBP, a class III secretory peroxidase derived from foxtail millet bran; ROS, reactive oxygen species; STAT3, signal transducer and activator of transcription 3; ISM, isthmin; AMOP, adhesion-associated domain in MUC4 and other proteins; HUVEC, human umbilical vein endothelial cell; TLR2, toll-like receptor 2; MDSCs, myeloid-derived suppressive cells. several solid tumors, such as pancreatic cancer, lung cancer, glioblastoma, and breast cancer, without obvious off-target effects or T cell infiltration in major organs (206)(207)(208)(209)(210)(211)(212). Moreover, several researchers have combined HSP70 binding peptide with other anticancer proteins or encased it within nanoparticles to precisely and effectively deliver chemotherapeutic drugs (213)(214)(215)(216)(217)(218)(219)(220).…”